Early Versus Late Ofatumumab (Kesimpta®) Use in Austrian RMS-Patients Over 2 Years

Clinical trial NCT05776888 · ACTIVE_NOT_RECRUITING

Trial details

NCT number: NCT05776888
Sponsor: Novartis Pharmaceuticals
Status: ACTIVE_NOT_RECRUITING
Study type: OBSERVATIONAL

Relapsing Multiple Sclerosis

Start date: 2023-07-10
Primary completion: 2026-08-31
Enrollment: 106

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.